Surufatinib in Combination With Tislelizumab in Subjects With Advanced Solid Tumors

Clinical trial NCT04579757 · TERMINATED

Trial details

NCT number: NCT04579757
Sponsor: Hutchmed
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Metastatic Solid Tumor Colorectal Cancer Neuroendocrine Tumors Small Cell Lung Cancer Gastric Cancer Soft Tissue Sarcoma Anaplastic Thyroid Cancer

Start date: 2021-03-05
Primary completion: 2024-04-30
Enrollment: 87

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.